- Home
- ESAB vs ELAN Comparison
ESAB vs ELAN Comparison
Compare ESAB & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESAB
- ELAN
- Stock Information
- Founded
- ESAB 1904
- ELAN 1954
- Country
- ESAB United States
- ELAN United States
- Employees
- ESAB N/A
- ELAN N/A
- Industry
- ESAB Office Equipment/Supplies/Services
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- ESAB Industrials
- ELAN Health Care
- Exchange
- ESAB Nasdaq
- ELAN Nasdaq
- Market Cap
- ESAB 7.1B
- ELAN 6.3B
- IPO Year
- ESAB N/A
- ELAN 2018
- Fundamental
- Price
- ESAB $128.54
- ELAN $12.03
- Analyst Decision
- ESAB Buy
- ELAN Buy
- Analyst Count
- ESAB 7
- ELAN 7
- Target Price
- ESAB $133.43
- ELAN $16.43
- AVG Volume (30 Days)
- ESAB 225.5K
- ELAN 3.8M
- Earning Date
- ESAB 02-27-2025
- ELAN 02-24-2025
- Dividend Yield
- ESAB 0.23%
- ELAN N/A
- EPS Growth
- ESAB 20.29
- ELAN N/A
- EPS
- ESAB 4.26
- ELAN 0.41
- Revenue
- ESAB $2,759,395,000.00
- ELAN $4,454,000,000.00
- Revenue This Year
- ESAB N/A
- ELAN $2.22
- Revenue Next Year
- ESAB $4.39
- ELAN $2.72
- P/E Ratio
- ESAB $30.14
- ELAN $29.13
- Revenue Growth
- ESAB 0.36
- ELAN 1.99
- 52 Week Low
- ESAB $85.79
- ELAN $11.11
- 52 Week High
- ESAB $135.97
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- ESAB 64.84
- ELAN 48.98
- Support Level
- ESAB $113.47
- ELAN $11.11
- Resistance Level
- ESAB $120.09
- ELAN $12.19
- Average True Range (ATR)
- ESAB 3.35
- ELAN 0.38
- MACD
- ESAB 1.09
- ELAN 0.07
- Stochastic Oscillator
- ESAB 98.20
- ELAN 70.77
About ESAB ESAB Corporation
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.8 billion in revenue in 2023.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.